Please upgrade your browser.
A new mobile device that allows bladder and kidney cancer to be detected at an early stage.
Physicians at Henry Ford Hospital successfully suctioned a cancerous tumor from a major vein in a patient with metastatic kidney cancer, clearing the way for him to undergo a minimally-invasive kidney removal.
Previous prognostic models for second-line systemic therapy in patients with metastatic renal cell carcinoma have not been studied in the setting of targeted therapy. We sought to validate the International Metastatic Renal Cell Carcinoma Database Consortium (IMDC) model in patients with metastatic renal cell carcinoma receiving next-line targeted therapy after progression on first-line targeted therapy.
We investigate the effect of pathologic tumor stage on the relationship between tumor size and risk of disease recurrence.
Investigators at Lund University (Sweden) have termed genetic variation in such minute samples as microvariation or microdiversity. They established the importance of this type of variation by analyzing millimeter sized specimens from 44 cases...
The aim of this research was to explore activation/deactivation of signaling pathways during cancerogenesis.
Objective: To evaluate the clinical efficacy of sorafenib as preoperative neoadjuvant therapy in patients with high risk renal cell carcinoma (RCC).
“This is a first of its kind meeting in Canada where an all-inclusive group will decide if we are on target, or if we need to refocus our efforts,” says Dr. Michael Jewett.
Levantinib is an oral molecular-targeted agent that selectively inhibits the activities of several different molecules involved in angiogenesis and tumor proliferation...
A new way to identify the most malignant tumors in children has been identified by researchers. The method involves studying genetic ‘micro-variation’, rather than the presence of individual mutations.
|Powered by NeonCRM|